XML 35 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Note 14 - Segment Data
 12 Months Ended
Mar. 31, 2016
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
Note 1
4
. Segment Data
 
We have four operating segments: Biological Indicators, Instruments, Continuous Monitoring and Cold Chain. The following tables set forth our segment information (in thousands):
 
 
 
Year Ended March
31, 201
6
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 33,649     $ 35,692     $ 10,792     $ 4,526     $ 84,659  
                                         
Gross profit
   $ 22,205     $ 23,223     $ 4,154     $ 1,831     $ 51,413  
Selling expenses
     1,734       3,848       1,642       276       7,500  
    $ 20,471     $ 19,375     $ 2,512     $ 1,555       43,913  
Reconciling items
(1)
                                     (28,358 )
Earnings before income taxes
                                   $ 15,555  
 
 
 
Year Ended March
31, 201
5
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 27,390     $ 33,054     $ 10,886     $ --     $ 71,330  
                                         
Gross profit
   $ 17,142     $ 20,763     $ 5,487     $ --     $ 43,392  
Selling expenses
     1,551       3,441       2,184       --       7,176  
    $ 15,591     $ 17,322     $ 3,303     $ --       36,216  
Reconciling items
(1)
                                     (20,869 )
Earnings before income taxes
                                   $ 15,347  
 
 
 
Year Ended March 31, 2014
 
 
 
Biological
Indicators
 
 
Instruments
 
 
Continuous Monitoring
 
 
Cold Chain
 
 
Total
 
Revenues
   $ 22,992     $ 26,389     $ 3,343     $ --     $ 52,724  
                                         
Gross profit
   $ 13,187     $ 16,904     $ 1,597     $ --     $ 31,688  
Selling expenses
     1,350       3,954       815       --       6,119  
    $ 11,837     $ 12,950     $ 782     $ --       25,569  
Reconciling items
(1)
                                     (12,466 )
Earnings before income taxes
                                   $ 13,103  
 
(1)
Reconciling items include general and administrative, research and development, and other expenses.
 
Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):
 
 
 
Year Ended March 31,
 
 
 
201
6
 
 
201
5
 
 
201
4
 
Revenues from unaffiliated customers
                        
United States
   $ 53,094     $ 45,798     $ 29,551  
Foreign
     31,565       25,532       23,173  
    $ 84,659     $ 71,330     $ 52,724  
 
 
No foreign country exceeds ten percent of total revenues.
 
 
 
 
March 31,
 
 
 
2016
 
 
2015
 
Total assets
                
Biological Indicators
   $ 56,724     $ 36,304  
Instruments
     49,077       44,401  
Continuous Monitoring
     26,881       31,558  
Cold Chain
     20,210       --  
Corporate and administrative
     7,856       5,057  
    $ 160,748     $ 117,320  
 
All long-lived assets are located in the United States except for $7,331,000 and $19,047,000 which are associated with our French and Canadian subsidiaries, respectively.